For example, the interaction between α4β1 integrin on cancer cells and fibronectin induce drug resistance in AML and CLL through the PI3K/AKT/BCL2 signaling pathway.268, 269. Here, AKT1 is linked to B-cell chronic lymphocytic leukemia.